Takeo Kuwata

1.2k total citations
80 papers, 941 citations indexed

About

Takeo Kuwata is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Takeo Kuwata has authored 80 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Virology, 39 papers in Infectious Diseases and 32 papers in Immunology. Recurrent topics in Takeo Kuwata's work include HIV Research and Treatment (69 papers), Immune Cell Function and Interaction (28 papers) and HIV/AIDS drug development and treatment (24 papers). Takeo Kuwata is often cited by papers focused on HIV Research and Treatment (69 papers), Immune Cell Function and Interaction (28 papers) and HIV/AIDS drug development and treatment (24 papers). Takeo Kuwata collaborates with scholars based in Japan, United States and Germany. Takeo Kuwata's co-authors include Masanori Hayami, Tatsuhiko Igarashi, Tomoyuki Miura, Eiji Ido, M. Hayami, Toshihide Shimada, Shuzo Matsushita, Vanessa M. Hirsch, Yoshimi Enose and Alicia Buckler‐White and has published in prestigious journals such as Journal of Virology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Takeo Kuwata

78 papers receiving 929 citations

Peers

Takeo Kuwata
Ronald L. Willey United States
Xinyao Yu United States
I W Park United States
S. Sharpe United Kingdom
Catherine Jett United States
Ron Plishka United States
Kristine Aldrich United States
Jim Stott United Kingdom
Phil Markham United States
Ronald L. Willey United States
Takeo Kuwata
Citations per year, relative to Takeo Kuwata Takeo Kuwata (= 1×) peers Ronald L. Willey

Countries citing papers authored by Takeo Kuwata

Since Specialization
Citations

This map shows the geographic impact of Takeo Kuwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Kuwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Kuwata more than expected).

Fields of papers citing papers by Takeo Kuwata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Kuwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Kuwata. The network helps show where Takeo Kuwata may publish in the future.

Co-authorship network of co-authors of Takeo Kuwata

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Kuwata. A scholar is included among the top collaborators of Takeo Kuwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Kuwata. Takeo Kuwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuji, Kohei, et al.. (2025). Antibody-Drug Conjugates Using CD4 Mimics and a Neutralizing Antibody as HIV-1 Entry Inhibitors. Journal of Medicinal Chemistry. 68(24). 25899–25911.
2.
Ngare, Isaac, Toong Seng Tan, Mako Toyoda, et al.. (2024). Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV. Viruses. 16(4). 555–555. 2 indexed citations
3.
Maeda, Yosuke, Mako Toyoda, Takeo Kuwata, et al.. (2024). Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2. International Journal of Molecular Sciences. 25(2). 1353–1353. 1 indexed citations
4.
Kuwata, Takeo, et al.. (2023). Idiotopes of antibodies against HIV‐1 CD4‐induced epitope shared with those against microorganisms. Immunology. 171(4). 534–548. 2 indexed citations
5.
Kuwata, Takeo, et al.. (2010). Isolation of Potent Neutralizing Monoclonal Antibodies from an SIV-Infected Rhesus Macaque by Phage Display. AIDS Research and Human Retroviruses. 27(5). 487–500. 19 indexed citations
6.
Kuwata, Takeo, Makoto Kodama, Akihiko Sato, et al.. (2007). Contribution of Monocytes to Viral Replication in Macaques during Acute Infection with Simian Immunodeficiency Virus. AIDS Research and Human Retroviruses. 23(3). 372–380. 10 indexed citations
7.
Miyake, Ariko, Yoshimi Enose, Sadayuki Ohkura, et al.. (2004). The quantity and diversity of infectious viruses in various tissues of SHIV-infected monkeys at the early and AIDS stages. Archives of Virology. 149(5). 943–955. 8 indexed citations
8.
Shimada, Toshihide, Hajime Suzuki, Takeo Kuwata, et al.. (2003). Comparative histopathological studies in the early stages of acute pathogenic and nonpathogenic SHIV-infected lymphoid organs. Virology. 306(2). 334–346. 4 indexed citations
9.
Iida, Tomoyuki, Takeo Kuwata, Hajime Suzuki, et al.. (2003). Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-γ. Archives of Virology. 149(4). 743–757. 8 indexed citations
10.
Ibuki, Kentaro, Toshihide Shimada, Takeo Kuwata, et al.. (2001). Characterization of Less Pathogenic Infectious Molecular Clones Derived from Acute-Pathogenic SHIV-89.6P Stock Virus. Virology. 282(1). 6–13. 20 indexed citations
11.
Miura, Tomoyuki, et al.. (2001). Construction of SIV/HIV-1 chimeric viruses having the IL-5 gene and determination of their ability to replicate and produce IL-5. Archives of Virology. 146(6). 1051–1062. 6 indexed citations
12.
Iida, Tohko, Hiroshi Ichimura, Toshihide Shimada, et al.. (2000). Role of Apoptosis Induction in Both Peripheral Lymph Nodes and Thymus in Progressive Loss of CD4+ Cells in SHIV-Infected Macaques. AIDS Research and Human Retroviruses. 16(1). 9–18. 19 indexed citations
13.
Akahata, Wataru, Eiji Ido, Toshihide Shimada, et al.. (2000). DNA Vaccination of Macaques by a Full Genome HIV-1 Plasmid Which Produces Noninfectious Virus Particles. Virology. 275(1). 116–124. 20 indexed citations
14.
Takehisa, Jun, Innocent Mboudjeka, Eiji Ido, et al.. (2000). Genetic Subtypes of HIV Type 1 in Republic of Congo. AIDS Research and Human Retroviruses. 16(7). 613–619. 36 indexed citations
15.
16.
Kuwata, Takeo, Tatsuhiko Igarashi, Kentaro Ibuki, et al.. (1999). Protection of Macaques against a SHIV with a Homologous HIV-1 Env and a Pathogenic SHIV-89.6P with a Heterologous Env by Vaccination with Multiple Gene-Deleted SHIVs. Virology. 265(2). 252–263. 35 indexed citations
17.
Bogers, Willy, Rob Dubbes, Peter ten Haaft, et al.. (1997). Comparison ofin Vitroandin VivoInfectivity of Different Clade B HIV-1 Envelope Chimeric Simian/Human Immunodeficiency Viruses inMacaca mulatta. Virology. 236(1). 110–117. 21 indexed citations
18.
Kuwata, Takeo, Tatsuo Shioda, Tatsuhiko Igarashi, et al.. (1996). Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1. AIDS. 10(12). 1331–1337. 21 indexed citations
20.
Shibata, Riri, Futoshi Hasebe, Yasushi Ami, et al.. (1994). Persistent Infection with SIVmac Chimeric Virus Having tat, rev, vpu, env and nef of HIV Type 1 in Macaque Monkeys. AIDS Research and Human Retroviruses. 10(8). 1021–1029. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026